Literature DB >> 28891091

Natural products to prevent drug resistance in cancer chemotherapy: a review.

Renyikun Yuan1, Ying Hou1, Wen Sun1, Jie Yu1, Xin Liu1, Yanan Niu1, Jin-Jian Lu1, Xiuping Chen1.   

Abstract

Chemotherapy is the standard internal medical treatment for cancer. However, the resistance of cancer cells to nearly all kinds of chemotherapeutic drugs and targeted drugs has become prevalent, and approximately 80-90% of deaths in cancer patients are directly or indirectly attributed to drug resistance. The progress of new drug research and development has also been impeded by the occurrence of drug resistance, which has emerged as a considerable challenge in cancer therapy. Fortunately, natural products with diverse chemical structures and pharmacological effects serve as effective substances against drug resistance. Since the discovery of a series of drug-resistant proteins, drug-efflux inhibition has been applied as the primary strategy to overcome drug resistance by maintaining the intracellular concentrations of chemotherapeutic drugs. Nonapoptotic cell death is considered an alternative strategy because most cases of drug resistance result in evasion and insensitivity to apoptosis. In this concise review, we summarize two strategies using natural products against drug resistance.
© 2017 New York Academy of Sciences.

Entities:  

Keywords:  cancer; drug resistance; natural products; nonapoptotic cell death

Mesh:

Substances:

Year:  2017        PMID: 28891091     DOI: 10.1111/nyas.13387

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  43 in total

1.  Functional Metabolomics and Chemoproteomics Approaches Reveal Novel Metabolic Targets for Anticancer Therapy.

Authors:  Chang Shao; Wenjie Lu; Haiping Hao; Hui Ye
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Therapeutic potential of marine peptides in cervical and ovarian cancers.

Authors:  Salman Ahmed; Haroon Khan; Sajad Fakhri; Michael Aschner; Wai San Cheang
Journal:  Mol Cell Biochem       Date:  2021-12-02       Impact factor: 3.396

Review 3.  Evodiamine as an anticancer agent: a comprehensive review on its therapeutic application, pharmacokinetic, toxicity, and metabolism in various cancers.

Authors:  Munmun Panda; Surya Kant Tripathi; Gokhan Zengin; Bijesh K Biswal
Journal:  Cell Biol Toxicol       Date:  2022-09-23       Impact factor: 6.819

Review 4.  Natural Products in Preventing Tumor Drug Resistance and Related Signaling Pathways.

Authors:  Chuansheng Yang; Zhikai Mai; Can Liu; Shuanghong Yin; Yantao Cai; Chenglai Xia
Journal:  Molecules       Date:  2022-05-30       Impact factor: 4.927

5.  Necroptosis-Related Genes Associated With Immune Activity and Prognosis of Colorectal Cancer.

Authors:  Xinyi Peng; Zhili Xu; Yong Guo; Ying Zhu
Journal:  Front Genet       Date:  2022-06-16       Impact factor: 4.772

6.  The Potential Mechanisms of Cinobufotalin Treating Colon Adenocarcinoma by Network Pharmacology.

Authors:  Jiyan Wang; Hongkai Chang; Meng Su; Huifang Zhao; Yaya Qiao; Yu Wang; Luqing Shang; Changliang Shan; Shuai Zhang
Journal:  Front Pharmacol       Date:  2022-06-23       Impact factor: 5.988

7.  Bioinformatics Analysis Reveals FOXM1/BUB1B Signaling Pathway as a Key Target of Neosetophomone B in Human Leukemic Cells: A Gene Network-Based Microarray Analysis.

Authors:  Shilpa Kuttikrishnan; Tariq Masoodi; Gulab Sher; Ajaz A Bhat; Kalyani Patil; Tamam El-Elimat; Nicholas H Oberlies; Cedric J Pearce; Mohmmad Haris; Aamir Ahmad; Feras Q Alali; Shahab Uddin
Journal:  Front Oncol       Date:  2022-07-01       Impact factor: 5.738

8.  Andrographolide Inhibits ER-Positive Breast Cancer Growth and Enhances Fulvestrant Efficacy via ROS-FOXM1-ER-α Axis.

Authors:  Tong Xu; Yanyu Jiang; Shuying Yuan; Li Zhang; Xihui Chen; Weili Zhao; Lili Cai; Biying Xiao; Lijun Jia
Journal:  Front Oncol       Date:  2022-05-09       Impact factor: 5.738

9.  Antitumor effect of Melaleuca alternifolia essential oil and its main component terpinen-4-ol in combination with target therapy in melanoma models.

Authors:  Marta Di Martile; Stefania Garzoli; Manuela Sabatino; Elisabetta Valentini; Simona D'Aguanno; Rino Ragno; Donatella Del Bufalo
Journal:  Cell Death Discov       Date:  2021-05-31

Review 10.  Oridonin and its derivatives for cancer treatment and overcoming therapeutic resistance.

Authors:  Xi Liu; Jimin Xu; Jia Zhou; Qiang Shen
Journal:  Genes Dis       Date:  2020-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.